Through the budget rectification, CNAS has obtained a significant increase in funds for cost-volume contracts, from 6.2 billion lei to 8.5 billion lei. This amount will allow the continuation of treatments for patients benefiting from innovative therapies and will facilitate access for other patients to essential medications. The president of CNAS, Horațiu-Remus Moldovan, emphasized the importance of this decision for public health and invited pharmaceutical manufacturers to participate in negotiations for new contracts.
Sources
Cum arată rectificarea bugetară pentru Sănătate. Cât primește CNAS de la Guvern pentru medicamente și terapii inovatoare
CNAS a obţinut creşterea plafonului de negociere pentru contractele cost-volum la 8,5 miliarde lei, faţă de 6,2 miliarde lei la începutul anului / Asigură continuitatea tratamentelor pentru peste 450.000 de pacienţi care beneficiază de terapii moderne
Latest News
07:44
Donald Trump challenges the U.S. Supreme Court. Signs executive orders to limit American citizenship granted by birth.
07:32
Power outages in the Republic of Moldova, due to the weather. The Bălți-Dnestrovsk power line is severely damaged.
07:15
MAE, the first clarifications after the arrest of a Romanian woman in Germany, in a case of espionage in favor of Russia
22:54
Iulia Navalnaya urges Russians to vote for Yabloko: the September elections, a legal referendum against the war
22:39
The air forces of Bulgaria, Romania, and Spain have signed a trilateral agreement for air policing operations within NATO.
See more news